Labcorp Holdings beats bottom-line estimates; updates FY outlook
Source: SeekingAlpha
2025-10-28 06:53:05 ET
More on Labcorp Holdings
- Labcorp Holdings: Currently Priced For Cash And Growth
- Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Labcorp Holdings Q3 2025 Earnings Preview
- Labcorp to offer Roche, Lilly Alzheimer's blood test starting in early 2026
- Seeking Alpha’s Quant Rating on Labcorp Holdings
Read the full article on Seeking Alpha
For further details see:
Labcorp Holdings beats bottom-line estimates; updates FY outlook
Labcorp Holdings Inc.
NASDAQ: LH
LH Trading
-2.49% G/L:
$268.26 Last:
163,586 Volume:
$272.99 Open:
LH Latest News
March 18, 2026 09:15:00 am
Illumina and Labcorp expand collaboration to broaden access to precision oncology testingFebruary 23, 2026 07:00:00 am
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform NationwideLH Stock Data
$23,563,496,000
82,071,000
N/A
505
N/A
Medical Diagnostics & Screening
Healthcare
US
Burlington
